{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:19:56Z","timestamp":1773980396557,"version":"3.50.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T00:00:00Z","timestamp":1370995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s40257-013-0033-9","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T08:26:54Z","timestamp":1370939214000},"page":"389-399","source":"Crossref","is-referenced-by-count":86,"title":["Barrier Repair Therapy in Atopic Dermatitis: An Overview"],"prefix":"10.1007","volume":"14","author":[{"given":"Kam Lun","family":"Hon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander K. C.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Barankin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,12]]},"reference":[{"key":"33_CR1","first-page":"73","volume":"11","author":"KL Hon","year":"2012","unstructured":"Hon KL, Wang SS, Leung TF. The atopic march: from skin to the airways. Iran J Allergy Asthma, Immunol. 2012;11:73\u20137.","journal-title":"Iran J Allergy Asthma, Immunol"},{"key":"33_CR2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.yapd.2007.03.013","volume":"54","author":"AK Leung","year":"2007","unstructured":"Leung AK, Hon KL, Robson WL. Atopic dermatitis. Adv Pediatr. 2007;54:241\u201373.","journal-title":"Adv Pediatr"},{"issue":"4","key":"33_CR3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1034\/j.1399-3038.2003.00052.x","volume":"14","author":"TF Leung","year":"2003","unstructured":"Leung TF, Ma KC, Hon KL, Lam CW, Wan H, Li CY, Chan IH. Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children. Pediatr Allergy Immunol. 2003;14(4):296\u2013301.","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"33_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF02850199","volume":"20","author":"AKC Leung","year":"2003","unstructured":"Leung AKC, Barber KA. Managing childhood atopic dermatitis. Adv Therapy. 2003;20(3):129\u201337.","journal-title":"Adv Therapy"},{"issue":"6","key":"33_CR5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.coi.2003.09.009","volume":"15","author":"DY Leung","year":"2003","unstructured":"Leung DY, Jain N, Leo HL. New concepts in the pathogenesis of atopic dermatitis. Curr Opin Immunol. 2003;15(6):634\u20138.","journal-title":"Curr Opin Immunol"},{"issue":"9352","key":"33_CR6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(03)12193-9","volume":"361","author":"DY Leung","year":"2003","unstructured":"Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361(9352):151\u201360.","journal-title":"Lancet"},{"issue":"1 Suppl 1","key":"33_CR7","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.jaad.2005.04.034","volume":"53","author":"W Abramovits","year":"2005","unstructured":"Abramovits W. Atopic dermatitis. J Am Acad Dermatol. 2005;53(1 Suppl 1):S86\u201393.","journal-title":"J Am Acad Dermatol"},{"key":"33_CR8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","volume":"2","author":"JM Hanifin","year":"1980","unstructured":"Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh). 1980;2:44\u20137.","journal-title":"Acta Derm Venereol (Stockh)"},{"issue":"1","key":"33_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(82)70001-5","volume":"6","author":"JM Hanifin","year":"1982","unstructured":"Hanifin JM. Atopic dermatitis. J Am Acad Dermatol. 1982;6(1):1\u201313.","journal-title":"J Am Acad Dermatol"},{"issue":"3 Suppl 2","key":"33_CR10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61385-3","volume":"93","author":"DY Leung","year":"2004","unstructured":"Leung DY, Nicklas RA, Li JT, Bernstein IL, Blessing-Moore J, Boguniewicz M, et al. Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol. 2004;93(3 Suppl 2):S1\u201321.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"33_CR11","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jaci.2006.07.026","volume":"118","author":"I Marenholz","year":"2006","unstructured":"Marenholz I, Nickel R, Ruschendorf F, Schulz F, Esparza-Gordillo J, Kerscher T, et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol. 2006;118(4):866\u201371.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"33_CR12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","volume":"38","author":"CN Palmer","year":"2006","unstructured":"Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis.[see comment]. Nat Genet. 2006;38(4):441\u20136.","journal-title":"Nat Genet"},{"issue":"5","key":"33_CR13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ng2020","volume":"39","author":"A Sandilands","year":"2007","unstructured":"Sandilands A, Terron-Kwiatkowski A, Hull PR, O\u2019Regan GM, Clayton TH, Watson RM, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet. 2007;39(5):650\u20134.","journal-title":"Nat Genet"},{"key":"33_CR14","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/sj.jid.5700876","volume":"127","author":"A Sandilands","year":"2007","unstructured":"Sandilands A, Smith FJ, Irvine AD, McLean WH. Filaggrin\u2019s fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol. 2007;127:1282\u20134.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"33_CR15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1744-313X.2009.00859.x","volume":"36","author":"G Ching","year":"2009","unstructured":"Ching G, Hon KL. Filaggrin null mutations in childhood atopic dermatitis among the Chinese. Int J Immunogenet. 2009;36(4):251\u20134.","journal-title":"Int J Immunogenet"},{"issue":"7","key":"33_CR16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10038-008-0293-z","volume":"53","author":"H Enomoto","year":"2008","unstructured":"Enomoto H, Hirata K, Otsuka K, Kawai T, Takahashi T, Hirota T, et al. Filaggrin null mutations are associated with atopic dermatitis and elevated levels of IgE in the Japanese population: a family and case-control study. J Hum Genet. 2008;53(7):615\u201321.","journal-title":"J Hum Genet"},{"issue":"4","key":"33_CR17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nrm1619","volume":"6","author":"E Candi","year":"2005","unstructured":"Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol. 2005;6(4):328\u201340.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"33_CR18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1542\/peds.2007-2232","volume":"122","author":"AC Krakowski","year":"2008","unstructured":"Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics. 2008;122(4):812\u201324.","journal-title":"Pediatrics"},{"issue":"6","key":"33_CR19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/pro.5560050618","volume":"5","author":"CD Thulin","year":"1996","unstructured":"Thulin CD, Taylor JA, Walsh KA. Microheterogeneity of human filaggrin: analysis of a complex peptide mixture using mass spectrometry. Protein Sci. 1996;5(6):1157\u201364.","journal-title":"Protein Sci"},{"issue":"4","key":"33_CR20","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.0022-202X.2004.22424.x","volume":"122","author":"DD Bikle","year":"2004","unstructured":"Bikle DD, Chang S, Crumrine D, Elalieh H, Man MQ, Choi EH, et al. 25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J Invest Dermatol. 2004;122(4):984\u201392.","journal-title":"J Invest Dermatol"},{"issue":"7","key":"33_CR21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1365-2222.2010.03522.x","volume":"40","author":"GM O\u2019Regan","year":"2010","unstructured":"O\u2019Regan GM, Irvine AD. The role of filaggrin in the atopic diathesis. Clin Exp Allergy. 2010;40(7):965\u201372.","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"33_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbpb.2006.06.012","volume":"145","author":"M Rousseau","year":"2006","unstructured":"Rousseau M, Bedouet L, Lati E, Gasser P, Le NK, Lopez E. Restoration of stratum corneum with nacre lipids. Comp Biochem Physiol B Biochem Mol Biol. 2006;145(1):1\u20139.","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"issue":"7","key":"33_CR23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1398-9995.2010.02326.x","volume":"65","author":"JM Jungersted","year":"2010","unstructured":"Jungersted JM, Scheer H, Mempel M, Baurecht H, Cifuentes L, Hogh JK, et al. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy. 2010;65(7):911\u20138.","journal-title":"Allergy"},{"issue":"3","key":"33_CR24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1523-1747.2000.00072.x","volume":"115","author":"J Hara","year":"2000","unstructured":"Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G. High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol. 2000;115(3):406\u201313.","journal-title":"J Invest Dermatol"},{"issue":"10","key":"33_CR25","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1038\/jid.2010.161","volume":"130","author":"J Ishikawa","year":"2010","unstructured":"Ishikawa J, Narita H, Kondo N, Hotta M, Takagi Y, Masukawa Y, et al. Changes in the ceramide profile of atopic dermatitis patients. J Invest Dermatol. 2010;130(10):2511\u20134.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"33_CR26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI21060","volume":"113","author":"DY Leung","year":"2004","unstructured":"Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest. 2004;113(5):651\u20137.","journal-title":"J Clin Invest"},{"issue":"5","key":"33_CR27","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3346\/jkms.2010.25.5.766","volume":"25","author":"KY Park","year":"2010","unstructured":"Park KY, Kim DH, Jeong MS, Li K, Seo SJ. Changes of antimicrobial peptides and transepidermal water loss after topical application of tacrolimus and ceramide-dominant emollient in patients with atopic dermatitis. J Korean Med Sci. 2010;25(5):766\u201371.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"33_CR28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00128071-200809010-00005","volume":"9","author":"KL Hon","year":"2008","unstructured":"Hon KL, Wong KY, Leung TF, Chow CM, Ng PC. Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD Index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis. Am J Clin Dermatol. 2008;9(1):45\u201350.","journal-title":"Am J Clin Dermatol"},{"issue":"15","key":"33_CR29","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","volume":"347","author":"PY Ong","year":"2002","unstructured":"Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis [see comment]. N Engl J Med. 2002;347(15):1151\u201360.","journal-title":"N Engl J Med"},{"issue":"2","key":"33_CR30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/eci.11.100","volume":"8","author":"J Heimall","year":"2012","unstructured":"Heimall J, Spergel JM. Filaggrin mutations and atopy: consequences for future therapeutics. Expert Rev Clin Immunol. 2012;8(2):189\u201397.","journal-title":"Expert Rev Clin Immunol"},{"issue":"9","key":"33_CR31","first-page":"22","volume":"4","author":"JQ Rosso Del","year":"2011","unstructured":"Del Rosso JQ, Levin J. The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin. J Clin Aesthet Dermatol. 2011;4(9):22\u201342.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"8","key":"33_CR32","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1194\/jlr.D800055-JLR200","volume":"50","author":"Y Masukawa","year":"2009","unstructured":"Masukawa Y, Narita H, Sato H, Naoe A, Kondo N, Sugai Y, et al. Comprehensive quantification of ceramide species in human stratum corneum. J Lipid Res. 2009;50(8):1708\u201319.","journal-title":"J Lipid Res"},{"issue":"6","key":"33_CR33","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1194\/jlr.M014456","volume":"52","author":"J Smeden van","year":"2011","unstructured":"van Smeden J, Hoppel L, van der Heijden R, Hankemeier T, Vreeken RJ, Bouwstra JA. LC\/MS analysis of stratum corneum lipids: ceramide profiling and discovery. J Lipid Res. 2011;52(6):1211\u201321.","journal-title":"J Lipid Res"},{"key":"33_CR34","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1194\/jlr.P030338","volume":"53","author":"M Janssens","year":"2012","unstructured":"Janssens M, van Smeden J, Gooris GS, Bras W, Portale G, Caspers PJ, et al. Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J Lipid Res. 2012;53:2755\u201366.","journal-title":"J Lipid Res"},{"issue":"2","key":"33_CR35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.sder.2008.04.005","volume":"27","author":"JL Sugarman","year":"2008","unstructured":"Sugarman JL. The epidermal barrier in atopic dermatitis. Semin Cutan Med Surg. 2008;27(2):108\u201314.","journal-title":"Semin Cutan Med Surg"},{"issue":"4","key":"33_CR36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/MOP.0b013e32832cfd3b","volume":"21","author":"PC Anderson","year":"2009","unstructured":"Anderson PC, Dinulos JG. Are the new moisturizers more effective? Curr Opin Pediatr. 2009;21(4):486\u201390.","journal-title":"Curr Opin Pediatr"},{"issue":"7","key":"33_CR37","first-page":"6","volume":"17","author":"D Sajic","year":"2012","unstructured":"Sajic D, Asiniwasis R, Skotnicki-Grant S. A look at epidermal barrier function in atopic dermatitis: physiologic lipid replacement and the role of ceramides. Skin Therapy Lett. 2012;17(7):6\u20139.","journal-title":"Skin Therapy Lett"},{"issue":"1\u20132","key":"33_CR38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0021-9673(01)00680-X","volume":"917","author":"J Bleton","year":"2001","unstructured":"Bleton J, Gaudin K, Chaminade P, Goursaud S, Baillet A, Tchapla A. Structural analysis of commercial ceramides by gas chromatography-mass spectrometry. J Chromatogr A. 2001;917(1\u20132):251\u201360.","journal-title":"J Chromatogr A"},{"issue":"11","key":"33_CR39","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1600-0625.2008.00737.x","volume":"17","author":"JS Kang","year":"2008","unstructured":"Kang JS, Yoon WK, Youm JK, Jeong SK, Park BD, Han MH, et al. Inhibition of atopic dermatitis-like skin lesions by topical application of a novel ceramide derivative, K6PC-9p, NC\/Nga mice. Exp Dermatol. 2008;17(11):958\u201364.","journal-title":"Exp Dermatol"},{"issue":"1","key":"33_CR40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/187221313804004673","volume":"7","author":"KL Hon","year":"2013","unstructured":"Hon KL, Leung AK. Use of ceramides and related products for childhood-onset eczema. Recent Pat Inflamm Allergy Drug Discov. 2013;7(1):12\u20139.","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"issue":"1","key":"33_CR41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2230.2009.03341.x","volume":"35","author":"KL Hon","year":"2010","unstructured":"Hon KL, Ching GK, Leung TF, Choi CY, Lee KK, Ng PC. Estimating emollient usage in patients with eczema. Clin Exp Dermatol. 2010;35(1):22\u20136.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"33_CR42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2230.2005.01748.x","volume":"30","author":"KL Hon","year":"2005","unstructured":"Hon KL, Leung T, Wong Y, Li A, Fok T, et al. A survey of bathing and showering practices in children with atopic eczema. Clin Exp Dermatol. 2005;30(4):351\u20134.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"33_CR43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1615\/CritRevImmunol.v28.i1.20","volume":"28","author":"S Sehra","year":"2008","unstructured":"Sehra S, Tuana FM, Holbreich M, Mousdicas N, Tepper RS, Chang CH, et al. Scratching the surface: towards understanding the pathogenesis of atopic dermatitis. Crit Rev Immunol. 2008;28(1):15\u201343.","journal-title":"Crit Rev Immunol"},{"issue":"2","key":"33_CR44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1067\/mjd.2002.124617","volume":"47","author":"SL Chamlin","year":"2002","unstructured":"Chamlin SL, Kao J, Frieden IJ, Sheu MY, Fowler AJ, Fluhr JW, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol. 2002;47(2):198\u2013208.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"33_CR45","first-page":"267","volume":"17","author":"L Maintz","year":"2007","unstructured":"Maintz L, Novak N. Getting more and more complex: the pathophysiology of atopic eczema. Eur J Dermatol. 2007;17(4):267\u201383.","journal-title":"Eur J Dermatol"},{"issue":"14","key":"33_CR46","doi-asserted-by":"crossref","first-page":"872","DOI":"10.12968\/bjon.2009.18.14.43356","volume":"18","author":"MJ Cork","year":"2009","unstructured":"Cork MJ, Danby S. Skin barrier breakdown: a renaissance in emollient therapy. Br J Nursing. 2009;18(14):872\u20137.","journal-title":"Br J Nursing"},{"issue":"8","key":"33_CR47","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/jid.2009.133","volume":"129","author":"MJ Cork","year":"2009","unstructured":"Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129(8):1892\u2013908.","journal-title":"J Invest Dermatol"},{"key":"33_CR48","doi-asserted-by":"crossref","first-page":"b4273","DOI":"10.1136\/bmj.b4273","volume":"339","author":"A Tarr","year":"2009","unstructured":"Tarr A, Iheanacho I. Should we use bath emollients for atopic eczema? BMJ. 2009;339:b4273.","journal-title":"BMJ"},{"issue":"23","key":"33_CR49","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.2165\/00003495-200464230-00003","volume":"64","author":"TC Roos","year":"2004","unstructured":"Roos TC, Geuer S, Roos S, Brost H. Recent advances in treatment strategies for atopic dermatitis. Drugs. 2004;64(23):2639\u201366.","journal-title":"Drugs"},{"issue":"3","key":"33_CR50","first-page":"93","volume":"93","author":"JH Baumer","year":"2008","unstructured":"Baumer JH. Atopic eczema in children, NICE. Arch Dis Child Educ Pract Ed. 2008;93(3):93\u20137.","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"33_CR51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/09546634.2012.672713","volume":"24","author":"KL Hon","year":"2013","unstructured":"Hon KL, Wang SS, Pong NH, Leung TF. The ideal moisturizer: a survey of parental expectations and practice in childhood-onset eczema. J Dermatol Treat. 2013;24:7\u201312.","journal-title":"J Dermatol Treat"},{"issue":"3","key":"33_CR52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3928\/0090-4481-20050301-09","volume":"34","author":"MA Dohil","year":"2005","unstructured":"Dohil MA, Eichenfield LF. A treatment approach for atopic dermatitis. Pediatr Ann. 2005;34(3):201\u201310.","journal-title":"Pediatr Ann"},{"issue":"1","key":"33_CR53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1473-2165.2010.00476.x","volume":"9","author":"R Bissonnette","year":"2010","unstructured":"Bissonnette R, Maari C, Provost N, Bolduc C, Nigen S, Rougier A, et al. A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis. J Cosmet Dermatol. 2010;9(1):16\u201321.","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"33_CR54","first-page":"531","volume":"10","author":"DW Miller","year":"2011","unstructured":"Miller DW, Koch SB, Yentzer BA, Clark AR, O\u2019Neill JR, Fountain J, et al. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial. J Drugs Dermatol. 2011;10(5):531\u20137.","journal-title":"J Drugs Dermatol"},{"issue":"8","key":"33_CR55","first-page":"1110","volume":"137","author":"SL Chamlin","year":"2001","unstructured":"Chamlin SL, Frieden IJ, Fowler A, Williams M, Kao J, Sheu M, et al. Ceramide-dominant, barrier-repair lipids improve childhood atopic dermatitis. Arch Dermatol. 2001;137(8):1110\u20132.","journal-title":"Arch Dermatol"},{"key":"33_CR56","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/09546634.2012.713461","volume":"24","author":"E Simpson","year":"2013","unstructured":"Simpson E, Bohling A, Bielfeldt S, Bosc C, Kerrouche N. Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor. J Dermatol Treat. 2013;24:122\u20135.","journal-title":"J Dermatol Treat"},{"issue":"5","key":"33_CR57","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1525-1470.2012.01809.x","volume":"29","author":"E Simpson","year":"2012","unstructured":"Simpson E, Trookman NS, Rizer RL, Preston N, Colon LE, Johnson LA, et al. Safety and tolerability of a body wash and moisturizer when applied to infants and toddlers with a history of atopic dermatitis: results from an open-label study. Pediatr Dermatol. 2012;29(5):590\u20137.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"33_CR58","first-page":"666","volume":"10","author":"A Frankel","year":"2011","unstructured":"Frankel A, Sohn A, Patel RV, Lebwohl M. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic Acid emollient foam in the treatment of patients with atopic dermatitis. J Drugs Dermatol. 2011;10(6):666\u201372.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"33_CR59","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2340\/00015555-0964","volume":"90","author":"M Loden","year":"2010","unstructured":"Loden M, Wiren K, Smerud K, Meland N, Honnas H, Mork G, et al. Treatment with a barrier-strengthening moisturizer prevents relapse of hand-eczema: an open, randomized, prospective, parallel group study. Acta Derm Venereol. 2010;90(6):602\u20136.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"33_CR60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000096915","volume":"214","author":"R Grimalt","year":"2007","unstructured":"Grimalt R, Mengeaud V, Cambazard F, Study Investigators\u2019 Group. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology. 2007;214(1):61\u20137.","journal-title":"Dermatology"},{"issue":"3","key":"33_CR61","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1185\/03007990903512156","volume":"26","author":"EL Simpson","year":"2010","unstructured":"Simpson EL. Atopic dermatitis: a review of topical treatment options. Curr Med Res Opin. 2010;26(3):633\u201340.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"33_CR62","first-page":"132","volume":"17","author":"KL Hon","year":"2011","unstructured":"Hon KL, Wang SS, Lau Z, Lee HC, Lee KK, Leung TF, et al. Pseudoceramide for childhood eczema: does it work? Hong Kong Med J. 2011;17(2):132\u20136.","journal-title":"Hong Kong Med J"},{"issue":"5","key":"33_CR63","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1684\/ejd.2011.1447","volume":"21","author":"YB Lee","year":"2011","unstructured":"Lee YB, Park HJ, Kwon MJ, Jeong SK, Cho SH. Beneficial effects of pseudoceramide-containing physiologic lipid mixture as a vehicle for topical steroids. Eur J Dermatol. 2011;21(5):710\u20136.","journal-title":"Eur J Dermatol"},{"issue":"4","key":"33_CR64","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1523-1747.2003.12470.x","volume":"121","author":"BD Park","year":"2003","unstructured":"Park BD, Youm JK, Jeong SK, Choi EH, Ahn SK, Lee SH. The characterization of molecular organization of multilamellar emulsions containing pseudoceramide and type III synthetic ceramide. J Invest Dermatol. 2003;121(4):794\u2013801.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"33_CR65","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4168\/aair.2011.3.2.96","volume":"3","author":"HJ Kim","year":"2011","unstructured":"Kim HJ, Park HJ, Yun JN, Jeong SK, Ahn SK, Lee SH. Pseudoceramide-containing physiological lipid mixture reduces adverse effects of topical steroids. Allergy Asthma Immunol Res. 2011;3(2):96\u2013102.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"3","key":"33_CR66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1473-2165.2011.00568.x","volume":"10","author":"ZD Draelos","year":"2011","unstructured":"Draelos ZD. A clinical evaluation of the comparable efficacy of hyaluronic acid-based foam and ceramide-containing emulsion cream in the treatment of mild-to-moderate atopic dermatitis. J Cosmet Dermatol. 2011;10(3):185\u20138.","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"33_CR67","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1529-8019.2012.01504.x","volume":"25","author":"K Nolan","year":"2012","unstructured":"Nolan K, Marmur E. Moisturizers: reality and the skin benefits. Dermatol Ther. 2012;25(3):229\u201333.","journal-title":"Dermatol Ther"},{"issue":"3","key":"33_CR68","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2340\/00015555-1064","volume":"91","author":"JM Jungersted","year":"2011","unstructured":"Jungersted JM, Hogh JK, Hellegren LI, Jemec GB, Agner T. Effects of topical corticosteroid and tacrolimus on ceramides and irritancy to sodium lauryl sulphate in healthy skin. Acta Derm Venereol. 2011;91(3):290\u20134.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"33_CR69","first-page":"87","volume":"81","author":"ZD Draelos","year":"2008","unstructured":"Draelos ZD. The effect of ceramide-containing skin care products on eczema resolution duration. Cutis. 2008;81(1):87\u201391.","journal-title":"Cutis"},{"issue":"10","key":"33_CR70","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1358\/dot.2008.44.10.1276838","volume":"44","author":"A Madaan","year":"2008","unstructured":"Madaan A. Epiceram for the treatment of atopic dermatitis. Drugs Today. 2008;44(10):751\u20135.","journal-title":"Drugs Today"},{"issue":"12","key":"33_CR71","first-page":"1106","volume":"8","author":"JL Sugarman","year":"2009","unstructured":"Sugarman JL, Parish LC. Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis. J Drugs Dermatol. 2009;8(12):1106\u201311.","journal-title":"J Drugs Dermatol"},{"issue":"12","key":"33_CR72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-5945-12-3","volume":"4","author":"AJ Lowe","year":"2012","unstructured":"Lowe AJ, Tang ML, Dharmage SC, Varigos G, Forster D, Gurrin LC, et al. A phase I study of daily treatment with a ceramide-dominant triple lipid mixture commencing in neonates. BMC Dermatol. 2012;4(12):3.","journal-title":"BMC Dermatol"},{"issue":"Suppl 2","key":"33_CR73","doi-asserted-by":"crossref","first-page":"i19","DOI":"10.1136\/archdischild-2011-300695","volume":"96","author":"H Cox","year":"2011","unstructured":"Cox H, Lloyd K, Williams H, Arkwright PD, Brown T, Clark C, et al. Emollients, education and quality of life: the RCPCH care pathway for children with eczema. Arch Dis Child. 2011;96(Suppl 2):i19\u201324.","journal-title":"Arch Dis Child"},{"issue":"4","key":"33_CR74","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1034\/j.1600-0846.2001.070401.x","volume":"7","author":"M Loden","year":"2001","unstructured":"Loden M, Andersson AC, Andersson C, Frodin T, Oman H, Lindberg M. Instrumental and dermatologist evaluation of the effect of glycerine and urea on dry skin in atopic dermatitis. Skin Res Technol. 2001;7(4):209\u201313.","journal-title":"Skin Res Technol"},{"issue":"4","key":"33_CR75","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000100884","volume":"214","author":"E Xhauflaire-Uhoda","year":"2007","unstructured":"Xhauflaire-Uhoda E, Thirion L, Pierard-Franchimont C, Pierard GE. Comparative effect of tacrolimus and betamethasone valerate on the passive sustainable hydration of the stratum corneum in atopic dermatitis. Dermatology. 2007;214(4):328\u201332.","journal-title":"Dermatology"},{"issue":"1","key":"33_CR76","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000111134","volume":"21","author":"M Breternitz","year":"2008","unstructured":"Breternitz M, Kowatzki D, Langenauer M, Elsner P, Fluhr JW. Placebo-controlled, double-blind, randomized, prospective study of a glycerol-based emollient on eczematous skin in atopic dermatitis: biophysical and clinical evaluation. Skin Pharmacol Physiol. 2008;21(1):39\u201345.","journal-title":"Skin Pharmacol Physiol"},{"issue":"1","key":"33_CR77","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-0625.2008.00756.x","volume":"18","author":"R Aschoff","year":"2009","unstructured":"Aschoff R, Schwanebeck U, Brautigam M, Meurer M. Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild-to-moderate atopic dermatitis. Exp Dermatol. 2009;18(1):24\u20139.","journal-title":"Exp Dermatol"},{"issue":"5","key":"33_CR78","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jaci.2009.03.032","volume":"123","author":"JM Jensen","year":"2009","unstructured":"Jensen JM, Pfeiffer S, Witt M, Brautigam M, Neumann C, Weichenthal M, et al. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol. 2009;123(5):1124\u201333.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"33_CR79","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1468-3083.2009.03303.x","volume":"23","author":"K Wiren","year":"2009","unstructured":"Wiren K, Nohlgard C, Nyberg F, Holm L, Svensson M, Johannesson A, et al. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. J Eur Acad Dermatol Venereol. 2009;23(11):1267\u201372.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"33_CR80","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1468-2494.2009.00495.x","volume":"31","author":"E Berardesca","year":"2009","unstructured":"Berardesca E, Abril E, Serio M, Cameli N. Effects of topical gluco-oligosaccharide and collagen tripeptide F in the treatment of sensitive atopic skin. Int J Cosmet Sci. 2009;31(4):271\u20137.","journal-title":"Int J Cosmet Sci"},{"issue":"2","key":"33_CR81","first-page":"171","volume":"10","author":"MT Woods","year":"2011","unstructured":"Woods MT, Brown PA, Baig-Lewis SF, Simpson EL. Effects of a novel formulation of fluocinonide 0.1% cream on skin barrier function in atopic dermatitis. J Drugs Dermatol. 2011;10(2):171\u20136.","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"33_CR82","first-page":"180","volume":"11","author":"LH Kircik","year":"2012","unstructured":"Kircik LH. Transepidermal water loss (TEWL) and corneometry with hydrogel vehicle in the treatment of atopic dermatitis: a randomized, investigator-blind pilot study. J Drugs Dermatol. 2012;11(2):180\u20134.","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"33_CR83","first-page":"635","volume":"49","author":"W Gehring","year":"1999","unstructured":"Gehring W, Bopp R, Rippke F, Gloor M. Effect of topically applied evening primrose oil on epidermal barrier function in atopic dermatitis as a function of vehicle. Arzneimittelforschung. 1999;49(7):635\u201342.","journal-title":"Arzneimittelforschung"},{"issue":"4","key":"33_CR84","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1468-3083.2009.03449.x","volume":"24","author":"F Hjalte","year":"2010","unstructured":"Hjalte F, Asseburg C, Tennvall GR. Cost-effectiveness of a barrier-strengthening moisturizing cream as maintenance therapy vs. no treatment after an initial steroid course in patients with atopic dermatitis in Sweden\u2014with model applications for Denmark, Norway and Finland. J Eur Acad Dermatol Venereol. 2010;24(4):474\u201380.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"33_CR85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40268-013-0004-x","volume":"13","author":"KL Hon","year":"2013","unstructured":"Hon KL, Pong NH, Wang SS, Lee VW, Luk NM, Leung TF. Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients. Drugs R D. 2013;13:37\u201342.","journal-title":"Drugs R D"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-013-0033-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-013-0033-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-013-0033-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T09:31:02Z","timestamp":1688290262000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-013-0033-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,12]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["33"],"URL":"https:\/\/doi.org\/10.1007\/s40257-013-0033-9","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,12]]}}}